Genmab has shared the first data on rinatabart sesutecan (Rina-S) in advanced endometrial cancer. The biotech reported a 50% unconfirmed response rate, beating the expectations of William Blair ...
Serial Circulating Tumor DNA Sequencing to Monitor Response and Define Acquired Resistance to Letrozole/Abemaciclib in Endometrial Cancer Using pretreatment tumor ...
Vijayashree Natarajan is senior vice president and head of technology at Omega Healthcare, which produces financial, administrative and clinical systems for healthcare organizations. Given her ...
Alpha Tau Medical targets major 2026 catalysts as Alpha DaRT gains momentum; key pancreatic & GBM readouts ahead. Read the full analysis here of DRTS stock.
In this study, the ResNeXt101 model framework was established to predict the gene mutation status in lung adenocarcinoma. The model was trained and validated using data from two cohorts: cohort 1, ...
The last time I wrote about Immuneering Corporation (IMRX), it was in a Seeking Alpha article entitled "Immuneering: Phase 1 Data Release IMM-1-104 Leads To Additional 2024 Milestone." With respect to ...
The government is drawing up a national cancer policy to help tackle the disease which is the second leading cause of death in Cayman.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results